PERCHERON THERAPEUTICS LIMITED - Announcements

0.00%

1.0¢

Market Cap $10.87M

Healthcare Biotechnology

Percheron Therapeutics Limited, formerly Antisense Therapeutics Limited, is a... Percheron Therapeutics Limited, formerly Antisense Therapeutics Limited, is a biotechnology company. The Company is engaged in developing and commercializing antisense pharmaceuticals for large unmet markets in rare diseases. The Company’s products include ATL1102 for Duchenne muscular dystrophy (DMD), ATL1103 for Acromegaly, and ATL1102 for Multiple Sclerosis (MS). ATL1102, is an antisense inhibitor targeting very late antigen 4 (VLA-4), an immune cell molecule. ATL1103 is a second-generation antisense drug designed to block growth hormone receptor (GHr) expression thereby reducing levels of the hormone insulin-like growth factor-I (IGF-I) in the blood and is a potential treatment for diseases associated with excessive growth hormone action. By inhibiting GHr production, ATL1103 in turn reduces IGF-I levels in the blood (serum). The Company is conducting a Phase II clinical trial of ATL1102 in DMD patients.More

RCE'S BREAKTHROUGH

Recce Pharmaceuticals (ASX:RCE) accelerates commercialisation with positive Phase II results.

Announcements

Filter Results

All Price Sensitive Only

PER	Change of Director's Interest Notice - Dr James Garner		20/05/25	192.46KB	Share
PER	Change of Directors Interest Notice - Dr Charmaine Gittleson		20/05/25	191.48KB	Share
PER	Notification regarding unquoted securities - PER		20/05/25	14.58KB	Share
PER	Letter to ineligible shareholders		14/05/25	129.63KB	Share
PER	Letter to eligible shareholders		14/05/25	186.82KB	Share
PER	Proposed issue of securities - PER		07/05/25	17.76KB	Share
PER	Bonus Loyalty Option Offer		07/05/25	586.65KB	Share
PER	Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	30/04/25	356.1KB	Share
PER	Results of General Meeting		24/04/25	144.51KB	Share
PER	Change of Interest of Substantial Holder from PVL		22/04/25	301.37KB	Share
PER	Percheron Therapeutics General Meeting		22/04/25	84.27KB	Share
PER	Change of Director's Interest Notice - Dr Ben Gil Price		03/04/25	207.48KB	Share
PER	Letter to Shareholders from the Board of Directors		02/04/25	192.74KB	Share
PER	Change of Director's Interest Notice - Dr James Garner		31/03/25	203.58KB	Share
PER	Notification of cessation of securities - PER		18/03/25	13.29KB	Share
PER	Notice of General Meeting		14/03/25	2.82MB	Share
PER	Notification of cessation of securities - PER		11/03/25	12.92KB	Share
PER	Response to ASX Query	PRICE SENSITIVE	06/03/25	340.69KB	Share
PER	Ceasing to be a substantial holder		06/03/25	164.31KB	Share
PER	Results of General Meeting		04/03/25	127.17KB	Share
PER	Change of Director's Interest Notice - Dr James Garner		26/02/25	203.52KB	Share
PER	Notices received under S203D and S249D of Corporations Act		25/02/25	195.46KB	Share
PER	Update on Partnering Progress		24/02/25	96.63KB	Share
PER	Change of Interest of Substantial Holder from PVL		21/02/25	331.95KB	Share
PER	Letter From The Chair and Half Year Accounts	PRICE SENSITIVE	19/02/25	1.26MB	Share
PER	Percheron Makes Rapid Progress in Partnering Discussions		12/02/25	101.93KB	Share
PER	Webinar Presentation - Phase IIb study of avicursen		06/02/25	766.12KB	Share
PER	Notification of cessation of securities - PER		03/02/25	12.92KB	Share
PER	Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	31/01/25	404.78KB	Share
PER	Notice of General Meeting		24/01/25	2.6MB	Share
PER	Change of Interest of Substantial Holder from PVL		17/01/25	155.55KB	Share
PER	Becoming a substantial holder		07/01/25	278.62KB	Share
PER	Notices received under s203D and s249D of Corporations Act		07/01/25	192.47KB	Share
PER	Becoming a substantial holder from PVL		06/01/25	190.04KB	Share
PER	Letter to Percheron Therapeutics Limited Shareholders		06/01/25	220.29KB	Share
PER	Change of Director's Interest Notice-Dr Charmaine Gittleson		31/12/24	201.79KB	Share
PER	Change of Director's Interest Notice - Dr James Garner		27/12/24	202.06KB	Share
PER	Change of Director's Interest Notice-Dr Charmaine Gittleson		20/12/24	201.75KB	Share
PER	Notification of cessation of securities - PER		20/12/24	13.51KB	Share
PER	Change in substantial holding		19/12/24	165.37KB	Share
PER	Topline Six-Month Results From Phase IIb Study of Avicursen	PRICE SENSITIVE	18/12/24	108.97KB	Share
PER	Trading Halt	PRICE SENSITIVE	16/12/24	188.35KB	Share
PER	Reorganisation of US Quoted Securities		03/12/24	97.41KB	Share
PER	Clinical Trial Update	PRICE SENSITIVE	02/12/24	103.19KB	Share
PER	Resignation of Joint Company Secretary		02/12/24	93.65KB	Share
PER	Notification regarding unquoted securities - PER		29/11/24	23.67KB	Share
PER	Change of Director's Interest Notice - Dr James Garner		28/11/24	202.01KB	Share
PER	Notice under S708A		27/11/24	201.63KB	Share
PER	Application for quotation of securities - PER		26/11/24	14.17KB	Share
PER	Change of Director's Interest Notice - Dr Ben Gil Price		25/11/24	203.9KB	Share
PER	Change of Director's Interest Notice Dr James Garner		25/11/24	203.67KB	Share
PER	Notification regarding unquoted securities - PER		25/11/24	18.06KB	Share
PER	Proposed issue of securities - PER		21/11/24	20.85KB	Share
PER	Proposed issue of securities - PER		21/11/24	23.78KB	Share
PER	Results of the Annual General Meeting		21/11/24	140.13KB	Share
PER	Annual General Meeting Management Presentation		21/11/24	1.01MB	Share
PER	Annual General Meeting - Chair's Address		21/11/24	156.87KB	Share
PER	Withdrawal of Resolutions from the Annual General Meeting		21/11/24	96.09KB	Share
PER	Change in substantial holding		15/11/24	184KB	Share
PER	Change of Director's Interest Notice - Dr James Garner		14/11/24	193.19KB	Share
PER	Application for quotation of securities - PER		14/11/24	15.45KB	Share
PER	Results of Share Purchase Plan	PRICE SENSITIVE	13/11/24	103.53KB	Share
PER	Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	31/10/24	363.3KB	Share
PER	Percheron launches post-trial access program		28/10/24	103.02KB	Share
PER	Share Purchase Plan Offer Booklet		28/10/24	630.99KB	Share
PER	Notice under S708A		25/10/24	201.61KB	Share
PER	Application for quotation of securities - PER		24/10/24	14.18KB	Share
PER	Proposed issue of securities - PER		23/10/24	17.51KB	Share
PER	Percheron to launch Share Purchase Plan	PRICE SENSITIVE	23/10/24	103.17KB	Share
PER	Update - Proposed issue of securities - PER		23/10/24	15.47KB	Share
PER	Percheron Holds International Advisory Boards		21/10/24	120.99KB	Share
PER	Addendum to 2024 Notice of Annual General Meeting		18/10/24	307.5KB	Share
PER	2024 Notice of Annual General Meeting		18/10/24	1.65MB	Share
PER	Proposed issue of securities - PER		18/10/24	16.06KB	Share
PER	Proposed issue of securities - PER		18/10/24	15.53KB	Share
PER	$13.0 million Institutional Placement	PRICE SENSITIVE	18/10/24	105.99KB	Share
PER	Trading Halt	PRICE SENSITIVE	16/10/24	187.92KB	Share
PER	Percheron Receives $2.35 million R&D Tax Incentive Rebate		08/10/24	87.65KB	Share
PER	Change of Company Auditor		01/10/24	86.92KB	Share
PER	Completion of avicursen (ATL1102) toxicology study	PRICE SENSITIVE	30/09/24	261.83KB	Share
PER	Percheron Therapeutics Limited Corporate Presentation		04/09/24	1.66MB	Share
PER	ATL1102 Shows Preclinical Activity in Autoimmune Epilepsy		03/09/24	139.18KB	Share
PER	Notice of date of AGM and other relevant dates		29/08/24	87.02KB	Share
PER	Appendix 4G and Corporate Governance Statement		29/08/24	541.35KB	Share
PER	Appendix 4E and Annual Report	PRICE SENSITIVE	29/08/24	5.21MB	Share
PER	Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	31/07/24	347.28KB	Share
PER	Notification regarding unquoted securities - PER		04/07/24	19.02KB	Share
PER	Deborah Ambrosini appointed as CFO & Company Secretary		17/06/24	91.3KB	Share
PER	Percheron appoints Dr Cathryn Clary as Chief Medical Advisor		03/06/24	89.48KB	Share
PER	Percheron to present at 2024 BIO International Convention		31/05/24	1.64MB	Share
PER	Phase IIb study of ATL1102 in DMD completes recruitment	PRICE SENSITIVE	29/05/24	109.16KB	Share
PER	Preliminary Results of 9 Month Toxicology Study of ATL1102		27/05/24	99.9KB	Share
PER	US Patent Granted for ATL1102 in Duchenne muscular dystrophy		20/05/24	94.63KB	Share
PER	WHO selects proposed INN for ATL1102		06/05/24	99.66KB	Share
PER	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/04/24	421.52KB	Share
PER	Change in substantial holding		26/04/24	224.86KB	Share
PER	ATL1102 Clinical Trial Update		02/04/24	254.91KB	Share
PER	ATL1102 Data presented at MDA Annual Conference		04/03/24	2.1MB	Share
PER	Half Yearly Report and Accounts	PRICE SENSITIVE	28/02/24	9.38MB	Share
PER	Percheron Therapeutics Limited Corporate Presentation		26/02/24	1.7MB	Share

PER Change of Director's Interest Notice - Dr James Garner
20/05/25		192.46KB	Share
PER Change of Directors Interest Notice - Dr Charmaine Gittleson
20/05/25		191.48KB	Share
PER Notification regarding unquoted securities - PER
20/05/25		14.58KB	Share
PER Letter to ineligible shareholders
14/05/25		129.63KB	Share
PER Letter to eligible shareholders
14/05/25		186.82KB	Share
PER Proposed issue of securities - PER
07/05/25		17.76KB	Share
PER Bonus Loyalty Option Offer
07/05/25		586.65KB	Share
PER Quarterly Activities Report and Appendix 4C
30/04/25	PRICE SENSITIVE	356.1KB	Share
PER Results of General Meeting
24/04/25		144.51KB	Share
PER Change of Interest of Substantial Holder from PVL
22/04/25		301.37KB	Share
PER Percheron Therapeutics General Meeting
22/04/25		84.27KB	Share
PER Change of Director's Interest Notice - Dr Ben Gil Price
03/04/25		207.48KB	Share
PER Letter to Shareholders from the Board of Directors
02/04/25		192.74KB	Share
PER Change of Director's Interest Notice - Dr James Garner
31/03/25		203.58KB	Share
PER Notification of cessation of securities - PER
18/03/25		13.29KB	Share
PER Notice of General Meeting
14/03/25		2.82MB	Share
PER Notification of cessation of securities - PER
11/03/25		12.92KB	Share
PER Response to ASX Query
06/03/25	PRICE SENSITIVE	340.69KB	Share
PER Ceasing to be a substantial holder
06/03/25		164.31KB	Share
PER Results of General Meeting
04/03/25		127.17KB	Share
PER Change of Director's Interest Notice - Dr James Garner
26/02/25		203.52KB	Share
PER Notices received under S203D and S249D of Corporations Act
25/02/25		195.46KB	Share
PER Update on Partnering Progress
24/02/25		96.63KB	Share
PER Change of Interest of Substantial Holder from PVL
21/02/25		331.95KB	Share
PER Letter From The Chair and Half Year Accounts
19/02/25	PRICE SENSITIVE	1.26MB	Share
PER Percheron Makes Rapid Progress in Partnering Discussions
12/02/25		101.93KB	Share
PER Webinar Presentation - Phase IIb study of avicursen
06/02/25		766.12KB	Share
PER Notification of cessation of securities - PER
03/02/25		12.92KB	Share
PER Quarterly Activities Report and Appendix 4C
31/01/25	PRICE SENSITIVE	404.78KB	Share
PER Notice of General Meeting
24/01/25		2.6MB	Share
PER Change of Interest of Substantial Holder from PVL
17/01/25		155.55KB	Share
PER Becoming a substantial holder
07/01/25		278.62KB	Share
PER Notices received under s203D and s249D of Corporations Act
07/01/25		192.47KB	Share
PER Becoming a substantial holder from PVL
06/01/25		190.04KB	Share
PER Letter to Percheron Therapeutics Limited Shareholders
06/01/25		220.29KB	Share
PER Change of Director's Interest Notice-Dr Charmaine Gittleson
31/12/24		201.79KB	Share
PER Change of Director's Interest Notice - Dr James Garner
27/12/24		202.06KB	Share
PER Change of Director's Interest Notice-Dr Charmaine Gittleson
20/12/24		201.75KB	Share
PER Notification of cessation of securities - PER
20/12/24		13.51KB	Share
PER Change in substantial holding
19/12/24		165.37KB	Share
PER Topline Six-Month Results From Phase IIb Study of Avicursen
18/12/24	PRICE SENSITIVE	108.97KB	Share
PER Trading Halt
16/12/24	PRICE SENSITIVE	188.35KB	Share
PER Reorganisation of US Quoted Securities
03/12/24		97.41KB	Share
PER Clinical Trial Update
02/12/24	PRICE SENSITIVE	103.19KB	Share
PER Resignation of Joint Company Secretary
02/12/24		93.65KB	Share
PER Notification regarding unquoted securities - PER
29/11/24		23.67KB	Share
PER Change of Director's Interest Notice - Dr James Garner
28/11/24		202.01KB	Share
PER Notice under S708A
27/11/24		201.63KB	Share
PER Application for quotation of securities - PER
26/11/24		14.17KB	Share
PER Change of Director's Interest Notice - Dr Ben Gil Price
25/11/24		203.9KB	Share
PER Change of Director's Interest Notice Dr James Garner
25/11/24		203.67KB	Share
PER Notification regarding unquoted securities - PER
25/11/24		18.06KB	Share
PER Proposed issue of securities - PER
21/11/24		20.85KB	Share
PER Proposed issue of securities - PER
21/11/24		23.78KB	Share
PER Results of the Annual General Meeting
21/11/24		140.13KB	Share
PER Annual General Meeting Management Presentation
21/11/24		1.01MB	Share
PER Annual General Meeting - Chair's Address
21/11/24		156.87KB	Share
PER Withdrawal of Resolutions from the Annual General Meeting
21/11/24		96.09KB	Share
PER Change in substantial holding
15/11/24		184KB	Share
PER Change of Director's Interest Notice - Dr James Garner
14/11/24		193.19KB	Share
PER Application for quotation of securities - PER
14/11/24		15.45KB	Share
PER Results of Share Purchase Plan
13/11/24	PRICE SENSITIVE	103.53KB	Share
PER Quarterly Activities Report and Appendix 4C
31/10/24	PRICE SENSITIVE	363.3KB	Share
PER Percheron launches post-trial access program
28/10/24		103.02KB	Share
PER Share Purchase Plan Offer Booklet
28/10/24		630.99KB	Share
PER Notice under S708A
25/10/24		201.61KB	Share
PER Application for quotation of securities - PER
24/10/24		14.18KB	Share
PER Proposed issue of securities - PER
23/10/24		17.51KB	Share
PER Percheron to launch Share Purchase Plan
23/10/24	PRICE SENSITIVE	103.17KB	Share
PER Update - Proposed issue of securities - PER
23/10/24		15.47KB	Share
PER Percheron Holds International Advisory Boards
21/10/24		120.99KB	Share
PER Addendum to 2024 Notice of Annual General Meeting
18/10/24		307.5KB	Share
PER 2024 Notice of Annual General Meeting
18/10/24		1.65MB	Share
PER Proposed issue of securities - PER
18/10/24		16.06KB	Share
PER Proposed issue of securities - PER
18/10/24		15.53KB	Share
PER $13.0 million Institutional Placement
18/10/24	PRICE SENSITIVE	105.99KB	Share
PER Trading Halt
16/10/24	PRICE SENSITIVE	187.92KB	Share
PER Percheron Receives $2.35 million R&D Tax Incentive Rebate
08/10/24		87.65KB	Share
PER Change of Company Auditor
01/10/24		86.92KB	Share
PER Completion of avicursen (ATL1102) toxicology study
30/09/24	PRICE SENSITIVE	261.83KB	Share
PER Percheron Therapeutics Limited Corporate Presentation
04/09/24		1.66MB	Share
PER ATL1102 Shows Preclinical Activity in Autoimmune Epilepsy
03/09/24		139.18KB	Share
PER Notice of date of AGM and other relevant dates
29/08/24		87.02KB	Share
PER Appendix 4G and Corporate Governance Statement
29/08/24		541.35KB	Share
PER Appendix 4E and Annual Report
29/08/24	PRICE SENSITIVE	5.21MB	Share
PER Quarterly Activities Report and Appendix 4C
31/07/24	PRICE SENSITIVE	347.28KB	Share
PER Notification regarding unquoted securities - PER
04/07/24		19.02KB	Share
PER Deborah Ambrosini appointed as CFO & Company Secretary
17/06/24		91.3KB	Share
PER Percheron appoints Dr Cathryn Clary as Chief Medical Advisor
03/06/24		89.48KB	Share
PER Percheron to present at 2024 BIO International Convention
31/05/24		1.64MB	Share
PER Phase IIb study of ATL1102 in DMD completes recruitment
29/05/24	PRICE SENSITIVE	109.16KB	Share
PER Preliminary Results of 9 Month Toxicology Study of ATL1102
27/05/24		99.9KB	Share
PER US Patent Granted for ATL1102 in Duchenne muscular dystrophy
20/05/24		94.63KB	Share
PER WHO selects proposed INN for ATL1102
06/05/24		99.66KB	Share
PER Quarterly Activities/Appendix 4C Cash Flow Report
30/04/24	PRICE SENSITIVE	421.52KB	Share
PER Change in substantial holding
26/04/24		224.86KB	Share
PER ATL1102 Clinical Trial Update
02/04/24		254.91KB	Share
PER ATL1102 Data presented at MDA Annual Conference
04/03/24		2.1MB	Share
PER Half Yearly Report and Accounts
28/02/24	PRICE SENSITIVE	9.38MB	Share
PER Percheron Therapeutics Limited Corporate Presentation
26/02/24		1.7MB	Share

REFRESH

1 2 3 4 5 6

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 1.0¢		Change 0.000(0.00%)		Mkt cap ! $10.87M

Open	High	Low	Value	Volume
1.0¢	1.0¢	1.0¢	$71.80K	7.180M

Buyers (Bids)

No.	Vol.	Price($)
1	4649246	1.0¢

Sellers (Offers)

Price($)	Vol.	No.
1.1¢	2600000	2

View Market Depth

No.	Vol.	Price($)
1	4649246	0.010
6	5659202	0.009
4	1260267	0.008
5	2282854	0.007
2	3200000	0.005

Price($)	Vol.	No.
0.011	2600000	2
0.012	1439598	4
0.013	1515000	3
0.014	2295834	4
0.015	1500000	1

Last trade - 15.21pm 13/06/2025 (20 minute delay)

PER (ASX) Chart

PERCHERON THERAPEUTICS LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories